Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3928]
News [11457]
Articles [47]
Editorials [10]
Conferences [201]
elearning [4]
ESMO 2024: Long-course radiotherapy is better than short-course for organ preservation in rectal cancer
ESMO 2024: Long-course radiotherapy is better than short-course for organ preservation in rectal cancer
Tumor-induced B cell changes reveal potential biomarker for treatment response in triple negative breast cancer
Tumor-induced B cell changes reveal potential biomarker for treatment response in triple negative breast cancer
Shorter-course radiation better option for breast cancer patients than conventional schedule
Shorter-course radiation better option for breast cancer patients than conventional schedule
Rwanda and BGI Genomics forge stronger ties in public health collaboration
Rwanda and BGI Genomics forge stronger ties in public health collaboration
WCLC 2024: Phase II study of taletrectinib shows clinically meaningful overall response and favorable safety in patients with ROS1+ non-small cell lung cancer
WCLC 2024: Phase II study of taletrectinib shows clinically meaningful overall response and favorable safety in...
WCLC 2024: Results from CARMEN-LC03 phase 3 study of tusamitamab ravtansine vs. docetaxel in previously treated advanced non-squamous NSCLC
WCLC 2024: Results from CARMEN-LC03 phase 3 study of tusamitamab ravtansine vs. docetaxel in previously treated...
PM2.5 exposure may affect lung cancer in women who have never smoked
PM2.5 exposure may affect lung cancer in women who have never smoked
WCLC 2024: LUMINOSITY trial demonstrates telisotuzumab vedotin shows durable response in Asian patients with c-Met protein-overexpressing EGFR WT nonsquamous NSCLC
WCLC 2024: LUMINOSITY trial demonstrates telisotuzumab vedotin shows durable response in Asian patients with c-Met...
Researchers compare tumour characteristics, survival outcome of different bile duct cancers
Researchers compare tumour characteristics, survival outcome of different bile duct cancers
Risk of secondary cancers after CAR T therapy may be similar to risk after other cancer treatments
Risk of secondary cancers after CAR T therapy may be similar to risk after other cancer treatments

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation